U.S. Food and Drug Administration

An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Topic Paragraphs

Image of Family who received injections

Don't delay, get your COVID-19 vaccine or booster today!

Getting vaccinated or receiving a booster if you’re already vaccinated is the best thing you can do to help protect yourself, family and friends.

Collage of images including drug vials with syringe, 3D rendering of coronavirus, and closeup of a person being administered a shot

Featured

FDA COVID-19 Response

FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.

Click here to view the Acting Commissioner's report

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

New Era Feature

New Era of Smarter Food Safety

A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

Mar 21

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters

Mar 18

FDA Roundup: March 18, 2022

More Press Announcements

Newsroom Meetings Testimony Speeches

Mar 21

Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (Epinephrine) Injection for Potential Manufacturing Defect

Drugs

Mar 21

Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity

Drugs

Mar 20

Fruit Fresh Up, Inc Recalls Products due to Possible Health Risk

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

Image of lab technician placing samples onto tray.

CDER Continues to Make Rare Diseases a Priority with Drug Approvals and Programming to Speed Therapeutic Development

Over the past decade or so, we have seen an upward trajectory in the percentage of drugs approved to treat rare or “orphan” diseases.

Image with a green background promoting "FDA's Rare Disease Day 2022" on March 4th.

Sharing Experiences in Rare Diseases Together

This year, the U.S. Food and Drug Administration is part of the worldwide community observing Rare Disease Week—February 28th through March 4th.

Image with an assortment of pills in the background, with a text overlay that reads "2021 Generic Drugs."

Innovation and Scientific Collaboration Moved the Generic Drug Program Forward In 2021

2021 was a productive year for the agency’s generic drug program.

Mar 22

An Acceptable Circular of Information for the Use of Human Blood and Blood Components

Biologics

Mar 22

Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4 Guidance for Industry

Biologics, Drugs, Medical Devices

Mar 15

Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products

Biologics

FDA Guidance Search

Jobs at FDA

Inspections and Compliance

MedWatch: Safety Alerts

Science & Research

FDA Organization

Import Program

Warning Letters

Combination Products

What does FDA regulate?

Criminal Investigations

Disposal of Unused Medicines

Emergency Preparedness

Top